| Product Code: ETC7661125 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import of rituximab to Israel in 2024 saw significant contributions from top exporting countries including Lithuania, Canada, Ireland, Germany, and China. Despite high concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the market continued to grow steadily with a Compound Annual Growth Rate (CAGR) of 10.09% from 2020 to 2024. The growth momentum remained strong in 2024 with a growth rate of 7.1% compared to the previous year, reflecting a promising outlook for the rituximab market in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Rituximab Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Rituximab Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Rituximab Market - Industry Life Cycle |
3.4 Israel Rituximab Market - Porter's Five Forces |
3.5 Israel Rituximab Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Israel Rituximab Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Rituximab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Israel |
4.2.2 Growing awareness and adoption of rituximab therapy in the Israeli healthcare system |
4.2.3 Favorable government policies and regulations supporting the use of rituximab in Israel |
4.3 Market Restraints |
4.3.1 High cost associated with rituximab treatment may limit access for some patients |
4.3.2 Potential side effects and safety concerns related to rituximab therapy |
4.3.3 Competition from alternative treatments or therapies in the Israeli market |
5 Israel Rituximab Market Trends |
6 Israel Rituximab Market, By Types |
6.1 Israel Rituximab Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Israel Rituximab Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Israel Rituximab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.1.4 Israel Rituximab Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.1.5 Israel Rituximab Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2 Israel Rituximab Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Rituximab Market Revenues & Volume, By Non-Hodgkin's Lymphoma, 2021- 2031F |
6.2.3 Israel Rituximab Market Revenues & Volume, By Chronic Lymphocytic Leukemia, 2021- 2031F |
6.2.4 Israel Rituximab Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.5 Israel Rituximab Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Rituximab Market Import-Export Trade Statistics |
7.1 Israel Rituximab Market Export to Major Countries |
7.2 Israel Rituximab Market Imports from Major Countries |
8 Israel Rituximab Market Key Performance Indicators |
8.1 Number of healthcare facilities offering rituximab therapy in Israel |
8.2 Patient adherence and compliance rates to rituximab treatment |
8.3 Number of clinical trials or research studies on rituximab conducted in Israel |
9 Israel Rituximab Market - Opportunity Assessment |
9.1 Israel Rituximab Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Israel Rituximab Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Rituximab Market - Competitive Landscape |
10.1 Israel Rituximab Market Revenue Share, By Companies, 2024 |
10.2 Israel Rituximab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here